720
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Screening Study to Determine the Prevalence of Airway Disease in Heroin Smokers

, , , &

References

  • Strang J, Griffiths P, Gossop M. Heroin smoking by “chasing the dragon”: origins and history. Addiction 1997; 92:673–683; discussion 685–695.
  • Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict 1999; 8:148–160.
  • Hughes S, Calverley PMA. Heroin inhalation and asthma. BMJ 1988; 297:1511–1512.
  • Cygan J, Trunsky M, Corbridge T. Inhaled heroin-induced status Asthmaticus: Five cases and a review of the literature. Chest 2000; 117:272–275.
  • Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorczuk DO. Heroin insufflation as a trigger for patients with life-threatening asthma. Chest 2003; 123:510–517.
  • Doshi V, Shenoy S, Ganesh A, Rishi MA, Molnar J, Henkle J. Profile of acute asthma exacerbation in drug users. Am J Ther 2014 Oct 10. ( Epub ahead of print)
  • Boto de los Bueis A, Pereira Vega A, Sánchez Ramos JL, Maldonado Pérez JA, Ayerbe Garcia R, García Jiménez D, Pujol de la Llave E. Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil. Chest 2002; 121:1223–1230.
  • Buster M, Rook L, van Brussel GH, van Ree J, van den Brink W. Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend 2002; 68:221–228.
  • Walker PP, Thwaite E, Amin S, Curtis J, Calverley PM. The association between heroin smoking and early onset emphysema. Chest 2015 May 28. doi: 10.1378/chest.15-0236. [ Epub ahead of print]
  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34:648–654.
  • Bestall JC, Paul E, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581–586.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH et al. ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3–95-yr age range: The global lung function 2012 equations. Eur Respir J 2012; 40(6):1324–1343.
  • Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5–40.
  • American Thoracic Society and European Respiratory Society. Standards for the Diagnosis and Treatment of Patients with Chronic Obstructive Pulmonary Disease, 2004. Available from: https://www.thoracic.org/copd-guidelines/resources/copddoc.pdf ( accessed 04 November, 2015)
  • Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London: National Clinical Guideline Centre, London; 2010. Available from: http://www.nice.org.uk/guidance/cg101 ( accessed 04 November, 2015).
  • Bischoff EWMA, Schermer TRJ, Bor H, Brown P, van Weel C, van den Bosch WJ. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract 2009; 59:927–933.
  • Jordan RE, Miller MR, Lam K-BH, Cheng KK, Marsh J, Adab P. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England. Thorax 2012; 67:600–605.
  • Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 2006; 28:945–952.
  • Griffiths C, Feder G, Wedzicha J, Foster G, Livingstone A, Marlowe GS. Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice. Respir Med 1999; 93:903–908.
  • Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011; 66:425–429.
  • Levine M, Iliescu ME, Margellos-Anast H, Estarziau M, Ansell DA. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 2005; 128:1951–1957.
  • Doshi V, Shenoy S, Ganesh A, Lankala S, Henkle J. Near fatal asthma in an inner city population. Am J Ther 2014; Oct 3. [ Epub ahead of print].
  • Kiljander T, Helin T, Venho K, Jaakkola A, Lehtimäki L. Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study. NPJ Prim Care Respir Med 2015; 25:15047.
  • Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med 2001; 7:43–61.
  • Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62:1058–1063.
  • Johnson MK, Smith RP, Morrison D, Laszlo G, White RJ. Large lung bullae in marijuana smokers. Thorax 2000; 55:340–342.
  • Yadavilli R, Collins A, Ding WY, Garner N, Williams J, Burhan H. Hospital readmissions with exacerbation of obstructive pulmonary disease in illicit drug smokers. Lung 2014; 192(5):669–673.
  • Whitfield M, Reed H, Harrison R, Davies C, McVeigh J. Drug and Alcohol Treatment in Cheshire and Merseyside 2012/13. Centre Public Heal Liverpool John Moores University. 2013. Available from: http://cph.org.uk/wp-content/uploads/2014/03/Drug-and-Alcohol-Treatment-in-Cheshire-and-Merseyside-12-13.pdf (accessed 04 November, 2015).
  • Hay G, dos Santos AR, Worsley J. Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2011/12: Sweep 8 Summary Report. Natl Treat Agency Subst Misuse, now part Public Heal Engl. 2012. Available from http://cph.org.uk/wp-content/uploads/2014/03/Drug-and-Alcohol-Treatment-in-Cheshire-and-Merseyside-12-13.pdf (accessed 04 November 2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.